Navigation Links
Targeting the protein AEG1 impairs human liver cancer growth in mice
Date:2/16/2009

Hepatocellular carcinoma (HCC) is a highly aggressive form of liver cancer and one of the 5 most common cancers worldwide. Devanand Sarkar and colleagues, at Virginia Commonwealth University School of Medicine, Richmond, have now identified a gene that is expressed at high levels in human HCC tumor samples and generates a protein important for HCC progression. They therefore suggest that targeting this gene (AEG1), or the protein that it generates, might provide a new therapeutic strategy for the treatment of HCC.

In the study, human liver cells were found to express only low levels of the protein AEG1, whereas human HCC tumor samples expressed very high levels. This was associated with an increase in the number of copies of the AEG1 gene in human HCC tumor samples. Functionally, human liver cell lines engineered to overexpress AEG1 grew faster than nonengineered cells and developed into highly aggressive tumors when transplanted into mice. In addition, knocking down levels of AEG1 in human HCC cell lines after they had been allowed to form a tumor in mice limited further growth. Further analysis revealed that the effects of AEG1 were mediated, in part, via its ability to activate the Wnt signaling pathway.


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1

Related medicine news :

1. Tobacco Companies Targeting Teens, Study Says
2. APIC 2009 Targeting Zero Initiative Offers Practical Tools, Evidence-Based Elimination Strategies to Prevent the Deadliest Healthcare-Associated Infections
3. Targeting Cancers Own Stem Cells to Fight Recurrence
4. Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting
5. Health Care Service Corporation Finds Success With Innovative Program Targeting Obesity Epidemic
6. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
7. EGFR-targeting antibody licensed to Abbott
8. Tackling a hard-to-treat childhood cancer by targeting epigenetic changes
9. Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes
10. NO on Prop 8 Campaign Slams Dishonest Mailer Targeting African-American Voters
11. Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... (HealthDay News) -- Clues to whether a person is at ... a new study suggests. Chemical changes to a gene ... spur suicidal thoughts and behaviors, the study,s authors explained. Spotting ... to a patient,s risk for suicide, they said. "Suicide ... been stymied in our prevention efforts because we have no ...
(Date:7/30/2014)... digital pathology market was valued at an estimated $250.2 million ... of 11.8%, to reach an estimated $437 million by 2018. ... expected to continue to rise in the coming years as ... pathologists to be efficient and this leads to improved quality ... was valued at $128.9 million and accounted for the largest ...
(Date:7/30/2014)... news release is available in French . ... led by Claude Gronfier (Inserm Unit 846: Stem Cell ... a study under real conditions on the body clocks ... The researchers have shown that a particular kind of ... rhythms are correctly synchronised despite the absence of sunlight. ...
(Date:7/30/2014)... with depression as preschoolers are likely to suffer from ... shows. , Depressed preschoolers were 2.5 times more likely ... school than kids who were not depressed at very ... of Medicine in St. Louis. , Their study is ... Journal of Psychiatry . , "It,s the same old ...
(Date:7/30/2014)... have found that a support program administered entirely ... symptoms in informal caregivers, such as family or ... published online in advance of print in the ... caring for people with Alzheimer,s disease or other ... deal of pressure," said principal investigator Geoffrey Tremont, ...
Breaking Medicine News(10 mins):Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5Health News:Dimly lit working environments: Correcting your body clock is possible! 2Health News:Dimly lit working environments: Correcting your body clock is possible! 3Health News:Dimly lit working environments: Correcting your body clock is possible! 4Health News:Many depressed preschoolers still suffer in later school years 2Health News:Many depressed preschoolers still suffer in later school years 3Health News:Study: Telephone support program beneficial for caregivers of those with dementia 2
... E-coli 0157, which is a stark eye-opener that adequate measures ... fatal food poisoning infection//. Three fresh cases, not connected to ... in South Lanarkshire, were confirmed yesterday. , ,A warning ... its dangers. But this by no means is to instigate ...
... at an IVF clinic almost destroyed their lives. In an interview ... they had to undergo when they came to know that the ... ,The couple had twins and it was quite obvious that ... by Leeds NHS Trust. "I was physically sick. The thought that ...
... says, as smoking, eating poor diets like too little fish, fruit and vegetables puts human ... ... ,Insufficient consumption of ... European Food Safety Authority, Netherland says. ,Dutch National Institute for Public Health and ...
... of exercise results from an increase in a protein ... and cause cell death. ,A study reports ... inhibits the action of another protein called insulin-like growth ... due to which the result appears. ,In ...
... people have died of heat and hundreds of people suffering ... Punjab province// , Daily Times newspaper reported Monday. ,At ... said. ,Most of the deaths were reported from ... in Multan and 48 degrees in Dera Ghazi Khan and ...
... Gurgaon (Haryana). When millions of disabled people are still dreaming ... has etched out// her own identity as a voice and ... the blind community faces a lot of barriers ranging from ... to be different can help them to overcome all of ...
Cached Medicine News:Health News:Unhealthy Diet Reduces Life Expectancy 2Health News:'Being Disabled Is Not a Barrier to Success' 2
(Date:7/30/2014)... PARIS , July 30, 2014 /PRNewswire/ ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... of alirocumab in people with hypercholesterolemia met their primary ... in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared ... monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... 2014  DigiPath, Inc. (OTCBB and OTCQB: DIGP), a ... cannabis testing and education markets, announced today that has ... not previously disclosed or, to its knowledge, any other ... "We have noticed unusual price and volume ... days," said Steve Barbee , CEO of DigiPath. ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... FDA approved Makena (hydroxyprogesterone caproate) in February 2011 ... births in women who have had at least one ... approved, a version of the active ingredient of Makena ... drug from a pharmacist who compounded the drug.  In ...
... N.J., Nov. 8, 2011 Covance Inc. (NYSE: ... Credit Suisse Healthcare Conference on Thursday, November 10, 2011 at ... the presentation at www.covance.com .  In order to register ... early. Covance, with headquarters in Princeton, New Jersey, ...
Cached Medicine Technology:FDA Statement on Makena 2Covance to Present at Credit Suisse 2011 Healthcare Conference 2
The Guidant Fineline II Sterox Atrial J is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Steroid eluting pacemaker leads...
Medicine Products: